Search Results - "JAKALIAN, Araz"
-
1
Revealing Atropisomer Axial Chirality in Drug Discovery
Published in ChemMedChem (07-03-2011)“…An often overlooked source of chirality is atropisomerism, which results from slow rotation along a bond axis due to steric hindrance and/or electronic…”
Get full text
Journal Article -
2
Fast, efficient generation of high-quality atomic charges. AM1-BCC model: II. Parameterization and validation
Published in Journal of computational chemistry (01-12-2002)“…We present the first global parameterization and validation of a novel charge model, called AM1‐BCC, which quickly and efficiently generates high‐quality…”
Get full text
Journal Article -
3
Solvated Interaction Energy (SIE) for Scoring Protein−Ligand Binding Affinities. 1. Exploring the Parameter Space
Published in Journal of chemical information and modeling (01-01-2007)“…We present a binding free energy function that consists of force field terms supplemented by solvation terms. We used this function to calibrate the solvation…”
Get full text
Journal Article -
4
Preclinical Profile of BI 224436, a Novel HIV-1 Non-Catalytic-Site Integrase Inhibitor
Published in Antimicrobial agents and chemotherapy (01-06-2014)“…BI 224436 is an HIV-1 integrase inhibitor with effective antiviral activity that acts through a mechanism that is distinct from that of integrase strand…”
Get full text
Journal Article -
5
Fast, efficient generation of high-quality atomic charges. AM1-BCC model: I. Method
Published in Journal of computational chemistry (30-01-2000)“…The AM1‐BCC method quickly and efficiently generates high‐quality atomic charges for use in condensed‐phase simulations. The underlying features of the…”
Get full text
Journal Article -
6
Enantiomeric Atropisomers Inhibit HCV Polymerase and/or HIV Matrix: Characterizing Hindered Bond Rotations and Target Selectivity
Published in Journal of medicinal chemistry (13-03-2014)“…An anthranilic acid series of allosteric thumb pocket 2 HCV NS5B polymerase inhibitors exhibited hindered rotation along a covalent bond axis, and the…”
Get full text
Journal Article -
7
Improved replicon cellular activity of non-nucleoside allosteric inhibitors of HCV NS5B polymerase: From benzimidazole to indole scaffolds
Published in Bioorganic & medicinal chemistry letters (01-10-2006)“…Benzimidazole-based allosteric inhibitors of the hepatitis C virus (HCV) NS5B polymerase were diversified to a variety of topologically related scaffolds…”
Get full text
Journal Article -
8
Minimizing the Contribution of Enterohepatic Recirculation to Clearance in Rat for the NCINI Class of Inhibitors of HIV
Published in ACS medicinal chemistry letters (12-06-2014)“…A scaffold replacement approach was used to identifying the pyridine series of noncatalytic site integrase inhibitors. These molecules bind with higher…”
Get full text
Journal Article -
9
An Analysis of the Interactions between the Sem−5 SH3 Domain and Its Ligands Using Molecular Dynamics, Free Energy Calculations, and Sequence Analysis
Published in Journal of the American Chemical Society (02-05-2001)“…The Src-homology-3 (SH3) domain of the Caenorhabditis elegans protein Sem−5 binds proline-rich sequences. It is reported that the SH3 domains broadly accept…”
Get full text
Journal Article -
10
Ligand Bioactive Conformation Plays a Critical Role in the Design of Drugs That Target the Hepatitis C Virus NS3 Protease
Published in Journal of medicinal chemistry (13-03-2014)“…A ligand-focused strategy employed NMR, X-ray, modeling, and medicinal chemistry to expose the critical role that bioactive conformation played in the design…”
Get full text
Journal Article -
11
Design of a brain-penetrant CDK4/6 inhibitor for glioblastoma
Published in Bioorganic & medicinal chemistry letters (15-08-2019)“…[Display omitted] CDK4 and CDK6 are kinases with similar sequences that regulate cell cycle progression and are validated targets in the treatment of cancer…”
Get full text
Journal Article -
12
Discovery of BI 224436, a Noncatalytic Site Integrase Inhibitor (NCINI) of HIV‑1
Published in ACS medicinal chemistry letters (10-04-2014)“…An assay recapitulating the 3′ processing activity of HIV-1 integrase (IN) was used to screen the Boehringer Ingelheim compound collection. Hit-to-lead and…”
Get full text
Journal Article -
13
Optimization of a Novel DEL Hit That Binds in the Cbl‑b SH2 Domain and Blocks Substrate Binding
Published in ACS medicinal chemistry letters (13-06-2024)“…We were attracted to the therapeutic potential of inhibiting Casitas B-lineage lymphoma proto-oncogene-b (Cbl-b), a RING E3 ligase that plays a critical role…”
Get full text
Journal Article -
14
Conformation-Based Restrictions and Scaffold Replacements in the Design of Hepatitis C Virus Polymerase Inhibitors: Discovery of Deleobuvir (BI 207127)
Published in Journal of medicinal chemistry (13-03-2014)“…Conformational restrictions of flexible torsion angles were used to guide the identification of new chemotypes of HCV NS5B inhibitors. Sites for rigidification…”
Get full text
Journal Article -
15
Investigation on the role of the tetrazole in the binding of thiotetrazolylacetanilides with HIV-1 wild type and K103N/Y181C double mutant reverse transcriptases
Published in Bioorganic & medicinal chemistry letters (15-02-2009)“…Different acyclic, cyclic and heterocyclic tetrazole replacements were investigated in order to evaluate the conformational and electronic contribution of the…”
Get full text
Journal Article -
16
Importance of Ligand Bioactive Conformation in the Discovery of Potent Indole-Diamide Inhibitors of the Hepatitis C Virus NS5B
Published in Journal of the American Chemical Society (03-11-2010)“…Significant advances have led to receptor induced-fit and conformational selection models for describing bimolecular recognition, but a more comprehensive view…”
Get full text
Journal Article -
17
Integrated Strategies for Identifying Leads That Target the NS3 Helicase of the Hepatitis C Virus
Published in Journal of medicinal chemistry (13-03-2014)“…Future treatments for individuals infected by the hepatitis C virus (HCV) will likely involve combinations of compounds that inhibit multiple viral targets…”
Get full text
Journal Article -
18
Anthranilic acid-based Thumb Pocket 2 HCV NS5B polymerase inhibitors with sub-micromolar potency in the cell-based replicon assay
Published in Bioorganic & medicinal chemistry letters (15-12-2013)“…Optimization efforts on the anthranilic acid-based Thumb Pocket 2 HCV NS5B polymerase inhibitors 1 and 2 resulted in the identification of multiple structural…”
Get full text
Journal Article -
19
Structure-based design of novel HCV NS5B thumb pocket 2 allosteric inhibitors with submicromolar gt1 replicon potency: Discovery of a quinazolinone chemotype
Published in Bioorganic & medicinal chemistry letters (15-07-2013)“…We describe the structure-based design of a novel lead chemotype that binds to thumb pocket 2 of HCV NS5B polymerase and inhibits cell-based gt1 subgenomic…”
Get full text
Journal Article -
20
Discovery of a novel series of non-nucleoside thumb pocket 2 HCV NS5B polymerase inhibitors
Published in Bioorganic & medicinal chemistry letters (01-05-2013)“…A novel series of non-nucleoside thumb pocket 2 HCV NS5B polymerase inhibitors were derived from a fragment-based approach using information from X-ray…”
Get full text
Journal Article